Enrichment and Purging of Stem Cells in the Treatment of Non-Hodgkin's Lymphoma
N/A
75 Years
Both
Lymphoma, Non-Hodgkin
Trial Information
Enrichment and Purging of Stem Cells in the Treatment of Non-Hodgkin's Lymphoma
To study the use of peripheral blood stem cells which have been treated in an effort to
remove tumor cells. The researchers hope to learn whether or not this will be more effective
in removing the tumor cells as compared to other methods of purging (the removal of cancer
cells).
Inclusion Criteria:
- relapsed NHLExclusion Criteria:- liver dysfunction
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
PCR positivity in peripheral blood cell collections after cyclophosphamide
Outcome Time Frame:
unknown
Safety Issue:
No
Principal Investigator
Robert S Negrin
Investigator Role:
Principal Investigator
Investigator Affiliation:
Stanford University
Authority:
United States: Institutional Review Board
Study ID:
BMT4IJ
NCT ID:
NCT00186355
Start Date:
October 2003
Completion Date:
February 2010
Related Keywords:
- Lymphoma, Non-Hodgkin
- Lymphoma
- Lymphoma, Non-Hodgkin
Name | Location |
|---|---|
| Stanford University School of Medicine | Stanford, California 94305-5317 |
